Nonsense-mediated mRNA decay due to a CACNA1C splicing mutation in a patient with Brugada syndrome

Brugada, 1992, Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report, J Am Coll Cardiol, 20, 1391, 10.1016/0735-1097(92)90253-J Antzelevitch, 2005, Brugada syndrome: report of the second consensus conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association, Circulation, 111, 659, 10.1161/01.CIR.0000152479.54298.51 Kapplinger, 2010, An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing, Heart Rhythm, 7, 33, 10.1016/j.hrthm.2009.09.069 Burashnikov, 2010, Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death, Heart Rhythm, 7, 1872, 10.1016/j.hrthm.2010.08.026 Holbrook, 2004, Nonsense-mediated decay approaches the clinic, Nat Genet, 36, 801, 10.1038/ng1403 Gong, 2007, Nonsense mutations in hERG cause a decrease in mutant mRNA transcripts by nonsense-mediated mRNA decay in human long-QT syndrome, Circulation, 116, 17, 10.1161/CIRCULATIONAHA.107.708818 Murray, 1999, Splicing mutations in KCNQ1: a mutation hot spot at codon 344 that produces in frame transcripts, Circulation, 100, 1077, 10.1161/01.CIR.100.10.1077 Tsuji, 2007, Mechanistic basis for the pathogenesis of long QT syndrome associated with a common splicing mutation in KCNQ1 gene, J Mol Cell Cardiol, 42, 662, 10.1016/j.yjmcc.2006.12.015 Fukuyama, 2013, L-type calcium channel mutations in Japanese patients with inherited arrhythmias, Circ J, 77, 1799, 10.1253/circj.CJ-12-1457 Antzelevitch, 2007, Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death, Circulation, 115, 442, 10.1161/CIRCULATIONAHA.106.668392 Napolitano, 2011, Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel, Circ Res, 108, 607, 10.1161/CIRCRESAHA.110.224279 Kanter, 2012, Brugada-like syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular conduction delay, Circulation, 125, 14, 10.1161/CIRCULATIONAHA.111.054007 Venetucci, 2012, Inherited calcium channelopathies in the pathophysiology of arrhythmias, Nat Rev Cardiol, 9, 561, 10.1038/nrcardio.2012.93 Hong, 2004, Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A, J Cardiovasc Electrophysiol, 15, 64, 10.1046/j.1540-8167.2004.03341.x Priori, 2002, Natural history of Brugada syndrome: insights for risk stratification and management, Circulation, 105, 1342, 10.1161/hc1102.105288 Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes: Document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 2013;10:1932–1963. Tsuchiya, 2002, Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome, J Cardiovasc Electrophysiol, 13, 698, 10.1046/j.1540-8167.2002.00698.x